122 related articles for article (PubMed ID: 28215647)
21. Genetic alterations in hepatocellular carcinoma: An update.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles.
Jiang M; Zeng Q; Dai S; Liang H; Dai F; Xie X; Lu K; Gao C
Mol Med Rep; 2017 Jan; 15(1):380-386. PubMed ID: 27959423
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma.
Imbeaud S; Ladeiro Y; Zucman-Rossi J
Semin Liver Dis; 2010 Feb; 30(1):75-86. PubMed ID: 20175035
[TBL] [Abstract][Full Text] [Related]
24. Identifying hepatocellular carcinoma-related genes and pathways by system biology analysis.
Wang P; Ouyang L; Zheng L; Wang Z
Ir J Med Sci; 2015 Jun; 184(2):357-64. PubMed ID: 24744259
[TBL] [Abstract][Full Text] [Related]
25. Bicluster and pathway enrichment analysis related to tumor progression of hepatocellular carcinoma.
Wang SY; Feng LY; Meng ZQ
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1191-7. PubMed ID: 25912578
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro.
Wang T; Ma S; Qi X; Tang X; Cui D; Wang Z; Chi J; Li P; Zhai B
Mol Med Rep; 2017 Mar; 15(3):1172-1178. PubMed ID: 28138696
[TBL] [Abstract][Full Text] [Related]
27. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.
Berger E; Vega N; Vidal H; Geloën A
Biotechnol J; 2012 Nov; 7(11):1395-404. PubMed ID: 22930530
[TBL] [Abstract][Full Text] [Related]
28. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
[TBL] [Abstract][Full Text] [Related]
30. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
31. Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique.
He TL; Zheng KL; Li G; Song B; Zhang YJ
Eur Rev Med Pharmacol Sci; 2014; 18(1):108-16. PubMed ID: 24452951
[TBL] [Abstract][Full Text] [Related]
32. Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma.
Takemoto N; Iizuka N; Yamada-Okabe H; Hamada K; Tamesa T; Okada T; Hashimoto K; Sakamoto K; Takashima M; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
Int J Oncol; 2005 Mar; 26(3):673-8. PubMed ID: 15703822
[TBL] [Abstract][Full Text] [Related]
33. Discovery of differentially expressed genes related to histological subtype of hepatocellular carcinoma.
Lee D; Choi SW; Kim M; Park JH; Kim M; Kim J; Lee IB
Biotechnol Prog; 2003; 19(3):1011-5. PubMed ID: 12790669
[TBL] [Abstract][Full Text] [Related]
34. Gene expression signature of human HepG2 cell line.
Costantini S; Di Bernardo G; Cammarota M; Castello G; Colonna G
Gene; 2013 Apr; 518(2):335-45. PubMed ID: 23357223
[TBL] [Abstract][Full Text] [Related]
35. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
37. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
[TBL] [Abstract][Full Text] [Related]
38. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
39. A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies.
Wang F; Wang R; Li Q; Qu X; Hao Y; Yang J; Zhao H; Wang Q; Li G; Zhang F; Zhang H; Zhou X; Peng X; Bian Y; Xiao W
Diagn Pathol; 2017 Jan; 12(1):4. PubMed ID: 28086821
[TBL] [Abstract][Full Text] [Related]
40. Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarray.
Kim BY; Lee JG; Park S; Ahn JY; Ju YJ; Chung JH; Han CJ; Jeong SH; Yeom YI; Kim S; Lee YS; Kim CM; Eom EM; Lee DH; Choi KY; Cho MH; Suh KS; Choi DW; Lee KH
Biochim Biophys Acta; 2004 Dec; 1739(1):50-61. PubMed ID: 15607117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
